Lipella Pharmaceuticals Inc. (LIPO) stock
LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.27KP/E –Yield –
Lipella Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Lipella Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2025 was -1387.9%. For fiscal 2024 it was -947.2%, against -1055.6% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -947.2% | +108.3 |
| FY2023 | Dec 31, 2023 | -1055.6% | +350.7 |
| FY2022 | Dec 31, 2022 | -1406.3% | −667.5 |
| FY2021 | Dec 31, 2021 | -738.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -1564.2% | −866.3 |
| Q1 FY2025 | Mar 31, 2025 | -1026.2% | −191.5 |
| Q4 FY2024 | Dec 31, 2024 | -835.7% | −231.9 |
| Q3 FY2024 | Sep 30, 2024 | -1815.6% | −511.7 |
| Q2 FY2024 | Jun 30, 2024 | -697.9% | +778.7 |
| Q1 FY2024 | Mar 31, 2024 | -834.7% | +83.9 |
| Q4 FY2023 | Dec 31, 2023 | -603.8% | −365.8 |
| Q3 FY2023 | Sep 30, 2023 | -1303.9% | +918.4 |
| Q2 FY2023 | Jun 30, 2023 | -1476.6% | – |
| Q1 FY2023 | Mar 31, 2023 | -918.6% | – |
| Q4 FY2022 | Dec 31, 2022 | -237.9% | – |
| Q1 FY2022 | Mar 31, 2022 | -2222.3% | – |
See a number that looks wrong?